ScholarIQanswers from OpenAlex
Neuro-Oncology
JournalCitation impact & published research
Neuro-Oncology is a journal indexed in ScholarIQ from OpenAlex.
What is the OpenAlex record for Neuro-Oncology?
ScholarIQopenalex
The OpenAlex for Neuro-Oncology is on the source record.
What are the most-cited papers on Neuro-Oncology?
ScholarIQmost cited works
TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL
Hai Yan, Patrick Killela, Zachary J. Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Laura A. Diaz, Allan H. Friedman, Henry S. Friedman, Gary L. Gallia, Beppino C. Giovanella, Arthur P. Grollman, Tong He, Yiping He, Ralph H. Hruban, George I. Jallo, Nils Mandahl, Alan K. Meeker, Fredrik Mertens, George J. Netto, B. Ahmed Rasheed, Gregory J. Riggins, Thomas A. Rosenquist, Mark Schiffman, I.-M. Shih, Dan Theodorescu, Michael Torbenson, Victor E. Velculescu, T. L. Wang, Nicolas Wentzensen, Laura D. Wood, M. Zhang, Patrick Healy, Rui Yang, Bill H. Diplas, Z. H. Wang, Paula K. Greer, Huishan Zhu, C. Wang, Austin B. Carpenter, James E. Herndon, Roger E. McLendon, K. W. Kinzler, Bert Vogelstein, Nikolaos G. Papadopoulos, D D Bigner
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
Kaisorn L. Chaichana, Ignacio Jusué-Torres, Rodrigo Navarro-Ramírez, Shaan M. Raza, María Pascual-Gallego, Aly Ibrahim, Marta Hernandez-Hermann, Luis Miguel Marín Gómez, Xiaobu Ye, Jon Weingart, Alessandro Olivi, Jaishri O. Blakeley, Gary L. Gallia, Michael Lim, Henry Brem, Alfredo Quiñones‐Hinojosa
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
Sushma Kunwar, Susan M. Chang, Manfred Westphal, Michael A. Vogelbaum, John H. Sampson, Gene H. Barnett, Mark E. Shaffrey, Zvi Ram, J Piepmeier, Michael D. Prados, David Croteau, Christoph Pedain, Pamela Leland, Syed R. Husain, Bharat Joshi, Raj K. Puri, for the PRECISE Study Group
Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
Ulrich Bogdahn, Peter Hau, Günther Stockhammer, N. K. Venkataramana, Anuspandana Mahapatra, Ashish Suri, Anandh Balasubramaniam, Sujit Nair, V. Oliushine, В. Е. Парфенов, И. Е. Повереннова, Menashe Zaaroor, Piotr Jachimczak, S. Ludwig, S. Schmaus, H. Heinrichs, K.-H. Schlingensiepen, the Trabedersen Glioma Study Group
Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery
G. Appelboom, Alexandre Detappe, Melissa A. LoPresti, Sijumon Kunjachan, Stefan Mitrasinovic, Serge Goldman, Steve D. Chang, Olivier Tillement